In our WGS data for GBM stem cells, tumors, and xenografts,3 we found that a subset of patient tumors and GBM stem cells harbored copy number gains at the IGF2 locus, consistent with our findings in mBT0309 (Figure 4E). This evidence concerns the gene IGF2 and glioblastoma.